123I‐β‐CIT and 123I‐IBZM‐SPECT scanning in levodopa‐naive Parkinson's disease
Identifieur interne : 000F18 ( Istex/Curation ); précédent : 000F17; suivant : 000F19123I‐β‐CIT and 123I‐IBZM‐SPECT scanning in levodopa‐naive Parkinson's disease
Auteurs : Wenning [Autriche] ; Eveline Donnemiller [Autriche] ; Roberta Granata [Autriche] ; Georg Riccabona [Autriche] ; Werner Poewe [Autriche]Source :
- Movement Disorders [ 0885-3185 ] ; 1998-05.
English descriptors
- KwdEn :
Abstract
Striatal dopamine transporter function and dopamine D2 receptor status were evaluated in 15 patients with early untreated Parkinson's disease using single photon emission tomography (SPECT) with 123I‐Iodo‐2β‐carboxymethoxy‐3β‐(4‐idiophenyl)tropane (β‐CIT) and 123I‐Iodobenzamide (IBZM) as pre‐ and postsynaptic ligands. Symptoms were unilateral in five patients and bilateral but asymmetric in 10 patients. Patients with bilateral symptoms had significantly lower 18‐hour striatal/cerebellar β‐CIT binding ratios (3.59 ± 0.79) than hemiparkinsonian patients (5.76 ± 1.48, p < 0.05) reflecting more advanced disease in this subgroup. Patients with bilateral parkinsonism were also found to have a significant side‐to‐side difference in striatal β‐CIT binding with more marked reduction contralateral to the presenting limb (18‐hour striatal/cerebellar ratio: 4.13 ± 0.78 [ipsilateral] versus 3.59 ± 0.79 [contralateral], p < 0.05). Dopamine D2 receptor binding as measured by IBZM was significantly elevated contralateral to the affected side in hemiparkinsonian patients (striatal/cerebellar ratio: 2.42 ± 0.90 [contralateral] versus 2.19 ± 0.80 [ipsilateral], p < 0.05). This asymmetric upregulation was absent in the patients with bilateral parkinsonism (striatal/cerebellar ratio: 1.85 ± 0.43 [contralateral to more severely affected side] versus 1.83 ± 0.34 [ipsilateral], p > 0.05). Our data suggest that postsynaptic dopamine receptor upregulation contralateral to the presenting side occurs in untreated unilateral PD and disappears in untreated bilateral (asymmetric) PD despite a greater loss of dopamine transporter function. Combined β‐CIT and IBZM SPECT studies may be helpful to monitor the progression of nigrostriatal dysfunction in early PD.
Url:
DOI: 10.1002/mds.870130311
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000F18
Links to Exploration step
ISTEX:54B5ADBC320F5D46B6105637C8FE732B03C96083Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">123I‐β‐CIT and 123I‐IBZM‐SPECT scanning in levodopa‐naive Parkinson's disease</title><author><name sortKey="Wenning" sort="Wenning" uniqKey="Wenning" last="Wenning">Wenning</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Innsbruck, Austria</mods:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Neurology, University of Innsbruck</wicri:regionArea></affiliation></author><author><name sortKey="Donnemiller, Eveline" sort="Donnemiller, Eveline" uniqKey="Donnemiller E" first="Eveline" last="Donnemiller">Eveline Donnemiller</name><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, University of Innsbruck, Austria</mods:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Nuclear Medicine, University of Innsbruck</wicri:regionArea></affiliation></author><author><name sortKey="Granata, Roberta" sort="Granata, Roberta" uniqKey="Granata R" first="Roberta" last="Granata">Roberta Granata</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Innsbruck, Austria</mods:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Neurology, University of Innsbruck</wicri:regionArea></affiliation></author><author><name sortKey="Riccabona, Georg" sort="Riccabona, Georg" uniqKey="Riccabona G" first="Georg" last="Riccabona">Georg Riccabona</name><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, University of Innsbruck, Austria</mods:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Nuclear Medicine, University of Innsbruck</wicri:regionArea></affiliation></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Innsbruck, Austria</mods:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Neurology, University of Innsbruck</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:54B5ADBC320F5D46B6105637C8FE732B03C96083</idno><date when="1998" year="1998">1998</date><idno type="doi">10.1002/mds.870130311</idno><idno type="url">https://api.istex.fr/document/54B5ADBC320F5D46B6105637C8FE732B03C96083/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000F18</idno><idno type="wicri:Area/Istex/Curation">000F18</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">123I‐β‐CIT and 123I‐IBZM‐SPECT scanning in levodopa‐naive Parkinson's disease</title><author><name sortKey="Wenning" sort="Wenning" uniqKey="Wenning" last="Wenning">Wenning</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Innsbruck, Austria</mods:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Neurology, University of Innsbruck</wicri:regionArea></affiliation></author><author><name sortKey="Donnemiller, Eveline" sort="Donnemiller, Eveline" uniqKey="Donnemiller E" first="Eveline" last="Donnemiller">Eveline Donnemiller</name><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, University of Innsbruck, Austria</mods:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Nuclear Medicine, University of Innsbruck</wicri:regionArea></affiliation></author><author><name sortKey="Granata, Roberta" sort="Granata, Roberta" uniqKey="Granata R" first="Roberta" last="Granata">Roberta Granata</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Innsbruck, Austria</mods:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Neurology, University of Innsbruck</wicri:regionArea></affiliation></author><author><name sortKey="Riccabona, Georg" sort="Riccabona, Georg" uniqKey="Riccabona G" first="Georg" last="Riccabona">Georg Riccabona</name><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, University of Innsbruck, Austria</mods:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Nuclear Medicine, University of Innsbruck</wicri:regionArea></affiliation></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Innsbruck, Austria</mods:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Neurology, University of Innsbruck</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1998-05">1998-05</date><biblScope unit="vol">13</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="438">438</biblScope><biblScope unit="page" to="445">445</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">54B5ADBC320F5D46B6105637C8FE732B03C96083</idno><idno type="DOI">10.1002/mds.870130311</idno><idno type="ArticleID">MDS870130311</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine receptors</term><term>IBZM</term><term>Parkinson's disease</term><term>SPECT imaging</term><term>β‐CIT</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Striatal dopamine transporter function and dopamine D2 receptor status were evaluated in 15 patients with early untreated Parkinson's disease using single photon emission tomography (SPECT) with 123I‐Iodo‐2β‐carboxymethoxy‐3β‐(4‐idiophenyl)tropane (β‐CIT) and 123I‐Iodobenzamide (IBZM) as pre‐ and postsynaptic ligands. Symptoms were unilateral in five patients and bilateral but asymmetric in 10 patients. Patients with bilateral symptoms had significantly lower 18‐hour striatal/cerebellar β‐CIT binding ratios (3.59 ± 0.79) than hemiparkinsonian patients (5.76 ± 1.48, p < 0.05) reflecting more advanced disease in this subgroup. Patients with bilateral parkinsonism were also found to have a significant side‐to‐side difference in striatal β‐CIT binding with more marked reduction contralateral to the presenting limb (18‐hour striatal/cerebellar ratio: 4.13 ± 0.78 [ipsilateral] versus 3.59 ± 0.79 [contralateral], p < 0.05). Dopamine D2 receptor binding as measured by IBZM was significantly elevated contralateral to the affected side in hemiparkinsonian patients (striatal/cerebellar ratio: 2.42 ± 0.90 [contralateral] versus 2.19 ± 0.80 [ipsilateral], p < 0.05). This asymmetric upregulation was absent in the patients with bilateral parkinsonism (striatal/cerebellar ratio: 1.85 ± 0.43 [contralateral to more severely affected side] versus 1.83 ± 0.34 [ipsilateral], p > 0.05). Our data suggest that postsynaptic dopamine receptor upregulation contralateral to the presenting side occurs in untreated unilateral PD and disappears in untreated bilateral (asymmetric) PD despite a greater loss of dopamine transporter function. Combined β‐CIT and IBZM SPECT studies may be helpful to monitor the progression of nigrostriatal dysfunction in early PD.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F18 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000F18 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:54B5ADBC320F5D46B6105637C8FE732B03C96083
|texte= 123I‐β‐CIT and 123I‐IBZM‐SPECT scanning in levodopa‐naive Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |